ArticleHistochemistry and cell biology2026
Functional suppression accompanies internal mitochondrial reorganization during cellular reprogramming.
Article in Histochemistry and cell biology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Mitochondrial Dysfunction: From Molecular Mechanisms to Modern Approaches for Basic and Clinical Research.Biomedicines · 2026Review
- May in focus in HCB: organelles-mitochondria and peroxisomes.Histochemistry and cell biology · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
Abstract
During the conversion of fibroblasts into induced pluripotent stem cells (iPSCs), cellular metabolism shifts from oxidative phosphorylation toward glycolysis; however, how functional and structural mitochondrial adaptations are coordinated remains incompletely understood. Here, we examined selected aspects of mitochondrial function, targeted gene expression, and ultrastructure in fibroblasts and iPSCs derived from healthy donors and patients with osteogenesis imperfecta (OI). Targeted gene expression analysis was performed in all four cell types, while functional and ultrastructural assays focused on OI-derived cells. Flow cytometry revealed reduced mitochondrial mass and reactive oxygen species (ROS) levels in iPSCs compared with fibroblasts. Mitochondrial membrane potential showed modestly reduced fluorescence depending on the probe used. Quantitative transmission electron microscopy demonstrated internal mitochondrial reorganization in iPSCs, including altered morphology and simplified cristae architecture, despite preservation of overall membrane integrity. These findings indicate that reprogramming induces coordinated functional downscaling and structural remodeling of mitochondria. Furthermore, differential expression of matrix metalloproteinases suggests that extracellular matrix remodeling accompanies metabolic adaptation during reprogramming.
Indexed as
Identifiers
42010006What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.